The Finish Line Inc reported consolidated net sales from continuing operations of $268.7 million for the thirteen weeks ended December 1, 2007, a decrease of 4.0% from consolidated net sales from continuing operations of $280.0 million for the thirteen weeks ended November 25, 2006.
Due to the shift of one week in the retail calendar due to last year's 53-week year, Q3LY included approximately $6.7 million of additional sales due to an additional week of the Back To School selling season. Total Company comparable store net sales for Q3 declined 3.6%.
By concept, Finish Line comparable store net sales declined 3.2% and Man Alive comparable store net sales decreased 9.8%. As a result of last year's 53-week year, Q3 comparable store net sales are compared to the thirteen weeks ended December 2, 2006.
The Company expects to report on a GAAP basis a loss per diluted share in the range of $.34 to $.36 for Q3. Included in the Q3 loss estimate is approximately $.12 per diluted share in expenses incurred in connection with the proposed merger with Genesco Inc and the related litigation and a $.07 loss per diluted share related to the discontinued operations of Paiva.
Excluding the expenses related to the Genesco matter and the losses associated with the discontinued operations of Paiva, the Company expects to report a loss per diluted share of $.15 - $.17 for Q3. Please see the reconciliation of expected loss per diluted share on a GAAP basis to expected loss per diluted share excluding the above amounts, a non-GAAP financial measure, in the table at the end of this release.